Synthesis of novel spin-labelled combretastatin A-4 derivatives as potential antineoplastic agents

Natural Product Research

Volumn 26, Issue 14, 2012, Pages 1271-1277

  Li, Xiao Jing ^a   Yang, Liu ^b   Liu, Ying Qian ^a   Li, Chong ^a  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU JIAOTONG UNIVERSITY   (China)

Author keywords

antineoplastic agents; combretastatin A 4; nitroxyl radical; spin label

Indexed keywords

ANTINEOPLASTIC AGENT; COMBRETASTATIN A4; IRINOTECAN;

ARTICLE; CLINICAL EVALUATION; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; LUNG CANCER; QUANTITATIVE ANALYSIS; SPIN LABELING;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; HEP G2 CELLS; HUMANS; MOLECULAR STRUCTURE; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84864061967     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2011.566222     Document Type: Article

References (26)

1. Ankel, EG, Lai, CS, Hopwood, LE, and, Zivkovic, Z. 1987. Cytotoxicity of commonly used nitroxide radical spin probes. Life Science, 40: 495-498.
2. Boye, O, and, Brossi, A. 1992. Tropolonic Colchicum alkaloids and allo congeners. In The alkaloids, Edited by: Brossi, A and Cordell, GA. 125-178. New York, NY: Academic Press.
3. Gadjeva, VG. 2002. Two spin labeled triazenes: Relationship between biochemical and biological activities. International Journal of Pharmaceutics, 247: 39-45.
4. Griggs, J, Metcalfe, JC, and, Hesketh, R. 2001. Targeting tumour vasculature: The development of combretastatin A4. The Lancet Oncology, 2: 82-87.
5. Hamel, E, and, Lin, CM. 1983. Interactions of combretastatin, a new plant-derived antimitotic agent, with tubulin. Biochemical Pharmacology, 32: 3864-3867.
6. Jin, Y, Chen, SW, and, Tian, X. 2006. Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin. Bioorganic and Medicinal Chemistry, 14: 3062-3068.
7. Krinitskaya, LA. 1980. The reaction of 4-oxo-2, 2, 6, 6-tetramethylpiperidine-1-oxyl and triacetonamine by iodine in base medium. Izv AN SSSR Ser Khim, 9: 2148-2152.
8. Li, WG, Zhang, XY, Wu, YJ, and, Tian, X. 2002. Antioxidative activity of spin labeled derivatives of podophyllic acid hydrazide. Acta Pharmacologica Sinica, 23: 727-732.
9. Lin, CM, Ho, HH, and, Pettit, GR. 1989. Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. Biochemistry, 28: 6984-6991.
10. Lin, CM, Singh, SB, Chu, PS, Dempcy, RO, Schmidt, JM, Pettit, GR, and, Hamel, E. 1988. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: A structure-activity study. Molecular Pharmacology, 34: 200-208.
11. Liu, YQ, and, Tian, X. 2005. Synthesis of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Synthetic Communications, 35: 2749-2758.
12. Liu, YQ, Tian, X, Yang, L, and, Zhan, ZC. 2008. First synthesis of novel spin-labeled derivatives of camptothecin as potential antineoplastic agents. European Journal of Medicinal Chemistry, 43: 2610-2614.
13. Liu, YQ, Yang, L, and, Tian, X. 2007. Podophyllotoxin: current perspectives. Current Bioactive Compounds, 3: 37-66.
14. Liu, YQ, Yang, L, Zhao, YL, and, Li, HY. 2010. Synthesis of novel derivatives of camptothecin as potential insecticides. Pesticide Biochemistry and Physiology, 90: 219-223.
15. Molho, D, and, Coillard, J. 1956. New methods of preparation of some stilbene derivatives. Bulletin de la Societe Chimique de France, 1: 78-93.
16. Mosmann, TJ. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65: 55-63.
17. Pettit, GR, Cragg, GM, Herald, DL, Schmidt, JM, and, Lobavanijaya, P. 1982. Isolation and structure of combretastatin. Canadian Journal of Chemistry, 60: 1374-1376.
18. Pettit, GR, and, Rhodes, MR. 1998. Antineoplastic agents 389. New syntheses of the combretastatin A-4 prodrug. Anti-Cancer Drug Design, 13: 183-191.
19. Pettit, GR, Singh, SB, Hamel, E, Lin, CM, Alberts, DS, and, Garcia-Kendall, D. 1989. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Cellular and molecular. Life Sciences, 45: 209-211.
20. Pettit, GR, Temple, C, Narayanan, VL, Varma, R, Simpson, MJ, Boyd, MR, Bansal, N. 1995. Antineoplastic agents 322. Synthesis of combretastatin A-4 prodrugs. Anti-Cancer Drug Design, 10: 299-309.
21. Sosnovsky, G. 1990. The quest for a predictive design of anticancer drugs. Pure and Applied Chemistry, 62: 289-294.
22. Sosnovsky, G, and, Li, SW. 1985. In the search for new anticancer drugs XII. Synthesis and biological evaluation of spin labeled nitrosoureas. Life Science, 36: 1479-1483.
23. Tian, X, Zhang, FM, and, Li, WG. 2002. Antitumor and antioxidant activity of spin labeled derivatives of podophyllotoxin (GP-1) and congeners. Life Science, 70: 2433-2443.
24. Wong, LL, Chwenk, R, and, Hsia, JC. 1974. New synthesis of nitroxyl radicals of the piperidine and tetrahydropyridine series. Canadian Journal of Chemistry, 52: 3381-3383.
25. Yang, L, Liu, YQ, Tan, H, Li, WG, and, Tian, X. 2007. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII. Natural Product Research, 21: 998-1008.
26. Zheleva, AM, and, Gadjeva, VG. 2001. Spin labelled nitrosoureas and triazenes and their non-labelled clinically used analogues a comparative study on their physicochemical properties and antimelanomic effects. International Journal of Pharmaceutics, 212: 257-266.